RE: 31%28 Jan 2023 12:14
Well, it fell back a little from a rise of 46% during the day.
As I posted earlier, Kanabo paid £14.5 Million for GP Services, plus one would assume a fair bit of cash from the £4.96Million we had at the beginning of October.
With a current Share price of circa 3p we still have an MCap of less than our cash & assets, so at this price the market still does not attribute any value to the expanding core business.
There is a fair amount of newsflow in the near term, and I believe the potential of the business far exceeds the current valuation.
There is an interesting interview for those that are holding the faith here, and it relates to GP Services obtaining access to NHS patient records.
My view is that the CEO is a particularly smart individual and has approached this business with a very big long term goal, witnessed by the very shrewd acquisition of GP Services, and the potential associated with this and access to the NHS.
The most recent RNS outlines the new IT platform is now up and running….
“Further to the above, Kanabo Group is committed to increasing patient access to prescribed medical cannabis in the UK by developing a new platform using its recently acquired UK subsidiary, The GP Service Ltd. The company is pleased to announce that all the regulatory approvals have been obtained, and the testing stage of the platform has begun. Additional updates will be provided in due course.”
Some very clever and solid foundations are being built to seriously scale this business, and the market is starting to witness this, and get behind the business.
I bought a fair chunk in the low 2’s and am continuing to add, my posting history will suggest I felt this Company was very undervalued when I came across the very depressed share price back in October/ November 2022.
Good luck all, this could become quite a belter.